ELMWOOD PARK, NJ and Chicago, IL (October 6, 2021) – BioReference Laboratories’ Richard Schwabacher is among Modern Healthcare’s 2021 class of Top 25 Emerging Leaders. Modern Healthcare, the leader in healthcare business news, research and data, annually honors emerging leaders all age 40 or under, who have made significant contributions in the areas of innovation […]
Search Results for: NEW
05
Oct
Oct
Every October, people all around the world join together for breast cancer awareness and show support for those affected by breast cancer. Women in the U.S. have a 1 in 8 lifetime risk of being diagnosed with breast cancer[i]. While it is the most common cancer in American women (except for skin cancer), death rates […]
20
Sep
Sep
As data from public health entities continues to emerge about COVID-19 and the Delta variant, we have learned it is more infectious and leading to increased transmissibility when compared with other variants. With the Delta variant accounting for more than 93% of new COVID-19 cases and being more than 2x as contagious as previous variants, according […]
03
Sep
Sep
September is Prostate Cancer Awareness Month! Other than skin cancer, prostate cancer is the most common cancer in American men. 1 The American Cancer Society’s estimates for prostate cancer in the United States for 2021 are: 248,530 new cases of prostate cancer 34,130 deaths from prostate cancer About 1 in 8 men will be diagnosed […]
26
Aug
Aug
Returning to In-Person Learning During COVID-19 The 2021 back-to-school season has been unlike any other – and the COVID-19 vaccine and COVID testing have been added to this year’s ‘back-to-school checklists’. With the Delta variant accounting for more than 93% of new COVID-19 cases, according to data from the Centers for Disease Control and Prevention […]
Directs Department of Health to Institute Universal Mask Requirement in All Schools Governor Pursuing Options to Mandate Vaccines for School Employees Launches COVID-19 Testing in Schools Program Using $585 Million in Federal Funds in Partnership with Counties and BOCES Establishes Additional Back-to-School Testing Program in Partnership with U.S. Department of Health and Human Services, Rite Aid and BioReference, […]
Press Release
BioReference Laboratories Acquires U.S. Ariosa Centralized Laboratory Prenatal Testing Business
16
Aug
Aug
ELMWOOD PARK, N.J., August 16, 2021 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the acquisition of the U.S. Ariosa centralized laboratory prenatal testing business from Roche. Ariosa’s non invasive prenatal screening (NIPS) test, the Harmony Prenatal Test, is one of the most widely studied tests utilized in prenatal screening. The test has been performed in […]
13
Aug
Aug
As you have probably seen in the news, genetic variants of SARS-CoV-2 have been emerging and circulating around the world throughout the COVID-19 pandemic. Most notable variants are the B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma) and B.1.617.2 (Delta) variants, which seem to spread more easily and quickly than other variants and may lead to more […]
03
Aug
Aug
Sexually Transmitted Infections and the Pandemic Since the start of the pandemic, Americans have been told to stay home and remain socially distant to stay healthy. While stay at home orders and quarantine offered protection from COVID-19, they came at a cost to routine health and wellness visits including STI testing. A study published in […]
